The Influence of 1α.25-Dihydroxyvitamin D3 Coating on Implant Osseointegration in the Rabbit Tibia
Objectives: This study aims to evaluate bone response to an implant surface modified by 1α,25-dihydroxyvitamin D3 [1.25-(OH)2D3] in vivo and the potential link between 1.25-(OH) 2D3 surface concentration and bone response. Material and Methods: Twenty-
Yoshihito +8 more
doaj
Background Whether real-time ultrasound guidance changes the minimum local anesthetic dose (MLAD/ED50) of intrathecal ropivacaine with dexmedetomidine for cesarean delivery under combined spinal–epidural anesthesia (CSEA) remains unclear.
Chai Lin +5 more
doaj +1 more source
Kai M Beeh,1 Aida Emirova,2 Hélène Prunier,2 Debora Santoro,3 Marie Anna Nandeuil2 1Insaf Respiratory Research Institute, Wiesbaden, Germany; 2Global Clinical Development, Chiesi S.A.S, Bois-Colombes, France; 3Global Clinical Development ...
Beeh KM +4 more
doaj
Exposure-response relationship of sintilimab in advanced gastric cancer: insights from time-dependent pharmacokinetics and biomarker integration for precision immunotherapy. [PDF]
Zhou J, Wang J, Liu L.
europepmc +1 more source
Exploring the Dose-Response Relationship Between Alcohol Consumption and Harm to Others in Australia. [PDF]
Smit K +3 more
europepmc +1 more source
Dose Exploration Based on Quantitative Pharmacokinetic Analysis of Monoclonal Antibodies for Pediatric Immune-Mediated Diseases: Current Evidence and Future Directions. [PDF]
Li S, Ma M, Wang N, Zheng X, Han X.
europepmc +1 more source
Exposure-Response Analyses of Datopotamab Deruxtecan (Dato-DXd), a TROP2-Directed Antibody-Drug Conjugate, in Advanced Non-small Cell Lung Cancer. [PDF]
Hong Y +10 more
europepmc +1 more source
Exposure-Response Analysis of Enfortumab Vedotin Plus Pembrolizumab as First-Line Therapy for Locally Advanced or Metastatic Urothelial Cancer. [PDF]
Chudasama VL +9 more
europepmc +1 more source
Therapeutic drug monitoring with non-anti-TNF advanced therapies in inflammatory bowel disease: current and evolving paradigms. [PDF]
Chater F, Butler TD, Limdi JK.
europepmc +1 more source

